March 24, 2026

Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: Impact of image registration and acquisition type

Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: Impact of image registration and acquisition type

Authors

  Prashant P. Nair, Joan Chick, Magali Nuixe, Bastien Lecoeur, Yu Xiao, Sian Cooper, Alison C. Tree, Petra J. van Houdt, Uwe Oelfke, Andreas Wetscherek

Published Date: 2025-10

https://www.sciencedirect.com/science/article/pii/S2405631625001563#f0010
File Type: www
Categories: Diffusion-Weighted Imaging (DWI), Quality Assurance, Apparent Diffusion Coefficient (ADC), Quality Control, QA, Diffusion Phantom Model 128, QC, NIST/RSNA/NCI Diffusion Phantom, QA/QC, NIST/QIBA Phantom, qCal-MR, MR-Linac, Radiation Therapy, mapping, Diffusion, NIST, Reproducibility